Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.
ClinicalTrials.gov study NCT05155709. IPD Sharing: YES. Countries: 7. Publications: 0.
Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00565058. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02441803. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT00114764. IPD Sharing: Not stated. Countries: 0. Publications: 1.
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With
ClinicalTrials.gov study NCT04214249. IPD Sharing: YES. Countries: 1. Publications: 0.
Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+
ClinicalTrials.gov study NCT02936089. IPD Sharing: YES. Countries: 0. Publications: 1.
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in
ClinicalTrials.gov study NCT02927262. IPD Sharing: YES. Countries: 21. Publications: 0.
Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
ClinicalTrials.gov study NCT00303667. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05028751. IPD Sharing: NO. Countries: 2. Publications: 0.
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01471444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (M
ClinicalTrials.gov study NCT04079296. IPD Sharing: NO. Countries: 2. Publications: 0.
Prognostic Value of CD318 in AML at Assiut University Hospital.
ClinicalTrials.gov study NCT04708444. IPD Sharing: Not stated. Countries: 0. Publications: 18.
CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML
ClinicalTrials.gov study NCT04620681. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors
ClinicalTrials.gov study NCT02519712. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00398983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS
ClinicalTrials.gov study NCT01442714. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-transplant Flotetuzumab for AML
ClinicalTrials.gov study NCT05506956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
ClinicalTrials.gov study NCT01700673. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
ClinicalTrials.gov study NCT03699475. IPD Sharing: NO. Countries: 1. Publications: 0.
Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01113502. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.